Further analysis of fibroblasts from diseased hearts with DCM and series of validation experiments revealed that PKNOX2 increased in fibroblast activation but decreased in advanced fibrosis formation (myofibroblast induction) during myocardial remodelling. Here, PKNOX2 is linked to familial dilated cardiomyopathy.